annual FCF:
$749.00M-$93.00M(-11.05%)Summary
- As of today (June 22, 2025), TEVA annual free cash flow is $749.00 million, with the most recent change of -$93.00 million (-11.05%) on December 31, 2024.
- During the last 3 years, TEVA annual FCF has risen by +$513.00 million (+217.37%).
- TEVA annual FCF is now -84.30% below its all-time high of $4.77 billion, reached on December 31, 2015.
Performance
TEVA Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$232.00M-$678.00M(-152.02%)Summary
- As of today (June 22, 2025), TEVA quarterly free cash flow is -$232.00 million, with the most recent change of -$678.00 million (-152.02%) on March 31, 2025.
- Over the past year, TEVA quarterly FCF has increased by +$16.00 million (+6.45%).
- TEVA quarterly FCF is now -115.98% below its all-time high of $1.45 billion, reached on December 31, 2014.
Performance
TEVA quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$765.00M+$16.00M(+2.14%)Summary
- As of today (June 22, 2025), TEVA TTM free cash flow is $765.00 million, with the most recent change of +$16.00 million (+2.14%) on March 31, 2025.
- Over the past year, TEVA TTM FCF has dropped by -$113.00 million (-12.87%).
- TEVA TTM FCF is now -85.13% below its all-time high of $5.14 billion, reached on June 30, 2015.
Performance
TEVA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
TEVA Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.1% | +6.5% | -12.9% |
| 3 y3 years | +217.4% | -12.6% | +30.8% |
| 5 y5 years | +235.9% | -231.1% | +85.2% |
TEVA Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.1% | +217.4% | -121.8% | +18.3% | -44.1% | +60.7% |
| 5 y | 5-year | -28.1% | +235.9% | -121.8% | +58.2% | -44.1% | +684.0% |
| alltime | all time | -84.3% | +627.1% | -116.0% | +58.2% | -85.1% | +684.0% |
TEVA Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$232.00M(-152.0%) | $765.00M(+2.1%) |
| Dec 2024 | $749.00M(-11.0%) | $446.00M(-18.2%) | $749.00M(-45.2%) |
| Sep 2024 | - | $545.00M(+8983.3%) | $1.37B(+101.5%) |
| Jun 2024 | - | $6.00M(-102.4%) | $679.00M(-22.7%) |
| Mar 2024 | - | -$248.00M(-123.3%) | $878.00M(+4.3%) |
| Dec 2023 | $842.00M(-19.2%) | $1.06B(-839.6%) | $842.00M(+38.5%) |
| Sep 2023 | - | -$144.00M(-170.2%) | $608.00M(-48.2%) |
| Jun 2023 | - | $205.00M(-172.2%) | $1.17B(+21.7%) |
| Mar 2023 | - | -$284.00M(-134.2%) | $964.00M(-7.5%) |
| Dec 2022 | $1.04B(+341.5%) | $831.00M(+97.4%) | $1.04B(+102.7%) |
| Sep 2022 | - | $421.00M(<-9900.0%) | $514.00M(+8.0%) |
| Jun 2022 | - | -$4.00M(-98.1%) | $476.00M(-18.6%) |
| Mar 2022 | - | -$206.00M(-168.0%) | $585.00M(+147.9%) |
| Dec 2021 | $236.00M(-63.0%) | $303.00M(-20.9%) | $236.00M(+168.2%) |
| Sep 2021 | - | $383.00M(+264.8%) | $88.00M(-167.2%) |
| Jun 2021 | - | $105.00M(-118.9%) | -$131.00M(+39.4%) |
| Mar 2021 | - | -$555.00M(-458.1%) | -$94.00M(-114.7%) |
| Dec 2020 | $638.00M(+186.1%) | $155.00M(-5.5%) | $638.00M(-29.3%) |
| Sep 2020 | - | $164.00M(+15.5%) | $902.00M(+0.9%) |
| Jun 2020 | - | $142.00M(-19.8%) | $894.00M(+116.5%) |
| Mar 2020 | - | $177.00M(-57.8%) | $413.00M(+85.2%) |
| Dec 2019 | $223.00M(-87.6%) | $419.00M(+168.6%) | $223.00M(-631.0%) |
| Sep 2019 | - | $156.00M(-146.0%) | -$42.00M(-150.0%) |
| Jun 2019 | - | -$339.00M(+2507.7%) | $84.00M(-81.3%) |
| Mar 2019 | - | -$13.00M(-108.4%) | $449.00M(-75.0%) |
| Dec 2018 | $1.79B(+32.9%) | $154.00M(-45.4%) | $1.79B(-19.6%) |
| Sep 2018 | - | $282.00M(+984.6%) | $2.23B(-11.9%) |
| Jun 2018 | - | $26.00M(-98.0%) | $2.53B(-7.9%) |
| Mar 2018 | - | $1.33B(+125.2%) | $2.75B(+103.6%) |
| Dec 2017 | $1.35B(-54.8%) | $592.00M(+1.5%) | $1.35B(+161.8%) |
| Sep 2017 | - | $583.00M(+140.9%) | $516.00M(-56.0%) |
| Jun 2017 | - | $242.00M(-466.7%) | $1.17B(-31.8%) |
| Mar 2017 | - | -$66.00M(-72.8%) | $1.72B(-42.5%) |
| Dec 2016 | $2.99B(-37.3%) | -$243.00M(-119.6%) | $2.99B(-35.0%) |
| Sep 2016 | - | $1.24B(+57.4%) | $4.60B(+7.4%) |
| Jun 2016 | - | $788.00M(-34.6%) | $4.28B(-10.9%) |
| Mar 2016 | - | $1.20B(-11.9%) | $4.80B(+0.7%) |
| Dec 2015 | $4.77B(+13.6%) | $1.37B(+48.1%) | $4.77B(-1.8%) |
| Sep 2015 | - | $923.00M(-29.6%) | $4.86B(-5.6%) |
| Jun 2015 | - | $1.31B(+12.1%) | $5.14B(+9.6%) |
| Mar 2015 | - | $1.17B(-19.5%) | $4.69B(+11.8%) |
| Dec 2014 | $4.20B(+90.3%) | $1.45B(+19.8%) | $4.20B(+29.2%) |
| Sep 2014 | - | $1.21B(+40.8%) | $3.25B(+44.2%) |
| Jun 2014 | - | $861.00M(+27.9%) | $2.25B(+10.3%) |
| Mar 2014 | - | $673.00M(+34.1%) | $2.04B(-7.5%) |
| Dec 2013 | $2.21B(-36.4%) | $502.00M(+132.4%) | $2.21B(-25.3%) |
| Sep 2013 | - | $216.00M(-66.8%) | $2.95B(-16.5%) |
| Jun 2013 | - | $650.00M(-22.4%) | $3.54B(-7.5%) |
| Mar 2013 | - | $838.00M(-33.0%) | $3.82B(+10.3%) |
| Dec 2012 | $3.47B(+12.6%) | $1.25B(+56.4%) | $3.47B(+4.2%) |
| Sep 2012 | - | $799.00M(-14.7%) | $3.33B(+21.7%) |
| Jun 2012 | - | $937.00M(+94.4%) | $2.74B(-5.6%) |
| Mar 2012 | - | $482.00M(-56.6%) | $2.90B(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $3.08B(-10.1%) | $1.11B(+439.3%) | $3.08B(+8.6%) |
| Sep 2011 | - | $206.00M(-81.2%) | $2.84B(-22.3%) |
| Jun 2011 | - | $1.10B(+64.9%) | $3.65B(+8.3%) |
| Mar 2011 | - | $666.00M(-23.3%) | $3.37B(-1.6%) |
| Dec 2010 | $3.43B(+29.1%) | $868.00M(-14.8%) | $3.43B(+3.7%) |
| Sep 2010 | - | $1.02B(+24.6%) | $3.30B(+6.1%) |
| Jun 2010 | - | $818.00M(+13.5%) | $3.11B(+17.8%) |
| Mar 2010 | - | $721.00M(-3.2%) | $2.64B(-0.5%) |
| Dec 2009 | $2.65B(+4.1%) | $745.00M(-10.1%) | $2.65B(-1.6%) |
| Sep 2009 | - | $829.00M(+138.9%) | $2.70B(+12.4%) |
| Jun 2009 | - | $347.00M(-52.7%) | $2.40B(-10.4%) |
| Mar 2009 | - | $733.00M(-7.0%) | $2.68B(+5.1%) |
| Dec 2008 | $2.55B(+100.6%) | $788.00M(+48.1%) | $2.55B(+18.1%) |
| Sep 2008 | - | $532.00M(-15.0%) | $2.16B(+17.9%) |
| Jun 2008 | - | $626.00M(+3.6%) | $1.83B(+19.5%) |
| Mar 2008 | - | $604.00M(+52.1%) | $1.53B(+20.5%) |
| Dec 2007 | $1.27B(-23.8%) | $397.00M(+94.6%) | $1.27B(-16.4%) |
| Sep 2007 | - | $204.00M(-37.6%) | $1.52B(-24.4%) |
| Jun 2007 | - | $327.00M(-4.7%) | $2.01B(+12.1%) |
| Mar 2007 | - | $343.00M(-46.9%) | $1.79B(+7.6%) |
| Dec 2006 | $1.67B(+57.4%) | $646.50M(-7.0%) | $1.67B(+39.3%) |
| Sep 2006 | - | $695.10M(+529.6%) | $1.20B(+48.8%) |
| Jun 2006 | - | $110.40M(-48.9%) | $804.50M(-23.4%) |
| Mar 2006 | - | $216.00M(+22.8%) | $1.05B(-0.9%) |
| Dec 2005 | $1.06B(+13.4%) | $175.90M(-41.8%) | $1.06B(-9.3%) |
| Sep 2005 | - | $302.20M(-15.2%) | $1.17B(-1.2%) |
| Jun 2005 | - | $356.50M(+58.2%) | $1.18B(+18.2%) |
| Mar 2005 | - | $225.40M(-20.8%) | $1.00B(+7.0%) |
| Dec 2004 | $935.00M(+123.1%) | $284.70M(-10.0%) | $935.00M(+21.1%) |
| Sep 2004 | - | $316.40M(+81.5%) | $771.80M(+44.0%) |
| Jun 2004 | - | $174.30M(+9.2%) | $535.90M(+30.1%) |
| Mar 2004 | - | $159.60M(+31.4%) | $412.00M(-1.7%) |
| Dec 2003 | $419.10M(+116.8%) | $121.50M(+50.9%) | $419.10M(+52.2%) |
| Sep 2003 | - | $80.50M(+59.7%) | $275.40M(+8.1%) |
| Jun 2003 | - | $50.40M(-69.8%) | $254.70M(-10.9%) |
| Mar 2003 | - | $166.70M(-850.9%) | $286.00M(+48.0%) |
| Dec 2002 | $193.30M(+39.0%) | -$22.20M(-137.1%) | $193.30M(-13.2%) |
| Sep 2002 | - | $59.80M(-26.8%) | $222.78M(+12.6%) |
| Jun 2002 | - | $81.70M(+10.4%) | $197.82M(+32.3%) |
| Mar 2002 | - | $74.00M(+916.2%) | $149.49M(+7.5%) |
| Dec 2001 | $139.08M(+82.5%) | $7.28M(-79.1%) | $139.08M(+5.5%) |
| Sep 2001 | - | $34.84M(+4.4%) | $131.80M(+35.9%) |
| Jun 2001 | - | $33.38M(-47.5%) | $96.96M(+52.5%) |
| Mar 2001 | - | $63.59M | $63.59M |
| Dec 2000 | $76.21M(-13.4%) | - | - |
| Dec 1999 | $87.98M(+396.1%) | - | - |
| Dec 1998 | $17.74M(-86.4%) | - | - |
| Dec 1997 | $130.20M(-191.6%) | - | - |
| Dec 1996 | -$142.10M(+822.7%) | - | - |
| Dec 1995 | -$15.40M(-65.3%) | - | - |
| Dec 1994 | -$44.40M(+398.9%) | - | - |
| Dec 1993 | -$8.90M(-60.1%) | - | - |
| Dec 1992 | -$22.30M(+68.9%) | - | - |
| Dec 1991 | -$13.20M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual free cash flow?
- What is the all time high annual FCF for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual FCF year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly free cash flow?
- What is the all time high quarterly FCF for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly FCF year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM free cash flow?
- What is the all time high TTM FCF for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM FCF year-on-year change?
What is Teva Pharmaceutical Industries Limited annual free cash flow?
The current annual FCF of TEVA is $749.00M
What is the all time high annual FCF for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual free cash flow is $4.77B
What is Teva Pharmaceutical Industries Limited annual FCF year-on-year change?
Over the past year, TEVA annual free cash flow has changed by -$93.00M (-11.05%)
What is Teva Pharmaceutical Industries Limited quarterly free cash flow?
The current quarterly FCF of TEVA is -$232.00M
What is the all time high quarterly FCF for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly free cash flow is $1.45B
What is Teva Pharmaceutical Industries Limited quarterly FCF year-on-year change?
Over the past year, TEVA quarterly free cash flow has changed by +$16.00M (+6.45%)
What is Teva Pharmaceutical Industries Limited TTM free cash flow?
The current TTM FCF of TEVA is $765.00M
What is the all time high TTM FCF for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM free cash flow is $5.14B
What is Teva Pharmaceutical Industries Limited TTM FCF year-on-year change?
Over the past year, TEVA TTM free cash flow has changed by -$113.00M (-12.87%)